ImpactAssets
VC Fund
Bethesda, United States
ImpactAssets is a nonprofit financial services firm that enables philanthropists and individual investors to engage in impact investing. It is a 501(c)3 organization.The firm offers impact investment products, including a donor advised fund called Giving Fund, impact investing notes, and educational resources to support individuals and advisorsinterested in impact investing and to help build the field of impact investing.ImpactAssets is based in Bethesda, Maryland.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries ImpactAssets invests in
Stages ImpactAssets invests in
Countries ImpactAssets invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $616k–$4M
- Angel
- $215k–$400k
- Series A
- $4.3M–$35M
Investment Focus
Industry
- Software 6 (19%)
- Health Care 6 (19%)
- Biotechnology 6 (19%)
- Artificial Intelligence 6 (19%)
- SaaS 4 (13%)
Stage
- Seed 12 (38%)
- Series A 6 (19%)
- Angel 3 (9%)
- Pre-Seed 3 (9%)
- Series B 2 (6%)
Country
- United States 21 (66%)
- Ghana 2 (6%)
- India 2 (6%)
- Mali 1 (3%)
- Chile 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alex Neckles
Officer, Operations
|
Officer, Operations | Total investments: 0 | Find email | |
Gabe DiClerico
CFO
|
CFO | Total investments: 0 | Find email | |
Jed Emerson
Chief Impact Strategist
|
Chief Impact Strategist | Total investments: 0 | Find email | |
Mackenzie Colgan
Regional Director, Distribution
|
Regional Director, Distribution | Total investments: 0 | Find email | |
Sally Boulter
Senior Officer, Client Experience & Strategic Development
|
Senior Officer, Client Experience & Strategic Development | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Salva Health
|
Salva Health is a healthcare solutions provider company that develops products to enable the prevention and early detection of diseases. | Seed / Sep 18, 2025 | |
Afterwind
|
Afterwind® exists to preserve natural resources for future generations by recycling glass fibre assets into circular advanced materials with full traceability.We help asset owners and industrial manufacturers in Advanced Materials, Renewable Energy, and Construction recover and reuse end-of-life and byproduct materials without compromising theiroriginal properties, including glass and carbon fibres, PET and PVC foams, and resin powders.Team Afterwind is expanding across Europe, working on- or near-site to help our clients cut costs, CO2, and risks, while supplying stable, high-quality, circular advanced materials that deliver on EU Taxonomy and green targets. | $615.6K / Seed / Apr 01, 2025 | |
Affinity
|
Affinity is a financial solutions company that provides financial inclusion, advisory, and literacy services. | $8M / Seed / Feb 11, 2025 | |
ChipAgents
|
Alpha Design AI is reinventing semiconductor design and verification through advanced AI agent techniques. Alpha Design AI is pioneering an AI-native approach to Electronic Design Automation (EDA), transforming how chips are designed and verified. Our flagship product, ChipAgents, aims to boost RTL design and verification productivity by 10x,driving innovation across industries with smarter, more efficient chip design. | $3.1M / Pre-Seed / Aug 07, 2024 | |
Slingshot Biosciences
|
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics. The company aims to bring simple, elegant, and cost-effective solutions to common problems facing research and development programs. | $15M / Series A / Apr 26, 2024 | |
Novobeing
|
Novobeing is an Immersive Patient Experience Platform that transforms hospital care with cutting-edge virtual and mixed reality (VR/MR) technologies. Designed to accelerate patient recovery and improve well-being, Novobeing offers a growing library of evidence-based programs that reduce anxiety, stress, and pain. Easy to use and seamlesslyintegrated into existing workflows, our self-administered platform empowers healthcare providers to deliver engaging and transformative care while improving clinical and economic outcomes. By combining immersive technology with a patient-centred approach, Novobeing is redefining the future of patient experience—one immersive experience at a time.With over 50+ evidence-based therapeutic and well-being programs, Novobeing supports in-patient care during hospitalization, cancer treatments, and diagnostic procedures. Our self-administered platform integrates seamlessly into existing workflows, requires minimal staff training, and optimizes resource use, making it easy to implement and scale across healthcare settings.Clinically validated and built for scalability, Novobeing helps healthcare providers enhance patient satisfaction, accelerate recovery, and reduce overall care costs—delivering measurable cost savings and transformative results in critical healthcare settings. | Jan 23, 2024 | |
Mad capital
|
Mad Capital provides finance for agricultural sector for building regenerative organic farmers. | $4M / Seed / Dec 13, 2022 | |
Cropin
|
Founded in 2010, Cropin is a pioneer in the Agtech space, having built the first global Intelligent Agriculture Cloud. Cropin's platform enables various stakeholders in the agri-ecosystem to leverage digitization and AI at scale to make decisions that increase efficiency, scale productivity, and strengthen sustainability. Cropin has workedwith 250+ customers and has digitized 16 million acres of farmland, improving the livelihoods of more than 7 million farmers. It has built the world's largest and most diverse farming data insights over a decade, spearheading a global 'Ag-intelligence' movement with a knowledge of 488 crops, and 10000 crop varieties in 56 countries. With its AI/ML platform tailor-made for the agriculture ecosystem, Cropin has computed 0.2 billion acres of farmlands across the globe. | $13.8M / Series D / Dec 09, 2022 | |
Goodr
|
Goodr is a sustainable food surplus management platform that leverages technology to reduce food waste and combat hunger. They provide an end-to-end solution for businesses seeking to earn money from their edible food waste by donating it to local nonprofit organizations. Their platform provides the logistics, analytics, and security for businessesto earn deductions under the PATH act in compliance with the Internal Revenue Services. Goodr’s blockchain-enabled platform also provides an IRS audit-friendly donation record, real-time food waste analytics, and community impact reports. Their model aims to provide a triple-win situation: improve business’ bottom line through tax deductions, reduce greenhouse emissions from landfills, and use edible food waste to reduce hunger. | $7.9M / Series A / Jun 23, 2022 | |
Massive Bio
|
Massive Bio, is an Artificial Intelligence (AI) powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development. Massive Bio combines technology, services and oncologysub-specialist expertise to maximize trial enrollment. Massive Bio is the first company that attacks controlling patient enrollment value chain; Massive Bio does patient identification through direct direct and indirect patient acquisition channels, pre-screening through virtual site, Just-In-Time (JIT) site activation and further analyzes real world data for drug discovery. One of the major differentiating point of Massive Bio is that the Company tackles “last mile” issues for trial enrollment to eliminate site and/or financial considerations of patients. Massive Bio is the go to partner for pharmaceutical companies and CROs to get the right patient at the right time. | $16.5M / Series A / Jun 02, 2022 | |
| See all 32 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does ImpactAssets invest in?
ImpactAssets invests primarily in Software, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 32 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is ImpactAssets's check size?
ImpactAssets typically joins rounds of $616k–$4M at Seed, $215k–$400k at Angel and $4.3M–$35M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ImpactAssets participates in.
How do I contact ImpactAssets?
Public channels for ImpactAssets include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ImpactAssets?
The team at ImpactAssets includes Alex Neckles (Officer, Operations), Gabe DiClerico (CFO) and Jed Emerson (Chief Impact Strategist), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
